Literature DB >> 10582903

Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania.

J Vila1, M Vargas, C Casals, H Urassa, H Mshinda, D Schellemberg, J Gascon.   

Abstract

Diarrhea caused by multidrug-resistant bacteria is an important public health problem among children in developing countries. The prevalence and antimicrobial susceptibility of diarrheagenic Escherichia coli in 346 children under 5 years of age in Ifakara, Tanzania, were studied. Thirty-eight percent of the cases of diarrhea were due to multiresistant enterotoxigenic E. coli, enteroaggregative E. coli, or enteropathogenic E. coli. Strains of all three E. coli categories showed high-level resistance to ampicillin, tetracycline, co-trimoxazole, and chloramphenicol but were highly susceptible to quinolones. Guidelines for appropriate use of antibiotics in developing countries need updating.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582903      PMCID: PMC89608          DOI: 10.1128/AAC.43.12.3022

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

Review 1.  Surveillance of antimicrobial resistance--an international perspective.

Authors:  R J Williams; M J Ryan
Journal:  BMJ       Date:  1998-09-05

2.  Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

Review 3.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with travelers' diarrhea.

Authors:  M. Vargas; J. Gascón; F Gallardo; M. T. Jimenez De Anta; J. Vila
Journal:  Clin Microbiol Infect       Date:  1998-02       Impact factor: 8.067

5.  An open, controlled study of two non-absorbable antibiotics for the oral treatment of paediatric infectious diarrhoea.

Authors:  L Frisari; V Viggiano; M Pelagalli
Journal:  Curr Med Res Opin       Date:  1997       Impact factor: 2.580

6.  Multidrug-resistant enteroaggregative Escherichia coli associated with persistent diarrhea in Kenyan children.

Authors:  W K Sang; J O Oundo; J K Mwituria; P G Waiyaki; M Yoh; T Iida; T Honda
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

Review 7.  Enteroaggregative Escherichia coli.

Authors:  J P Nataro; T Steiner; R L Guerrant
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

8.  Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo.

Authors:  R E Black; M M Levine; M L Clements; L Cisneros; V Daya
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

9.  Enteropathogenicity markers in Escherichia coli isolated from infants with acute diarrhoea and healthy controls in Rio de Janeiro, Brazil.

Authors:  A C Rosa; A T Mariano; A M Pereira; A Tibana; T A Gomes; J R Andrade
Journal:  J Med Microbiol       Date:  1998-09       Impact factor: 2.472

  9 in total
  23 in total

1.  In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea.

Authors:  J M Sierra; J Ruiz; M M Navia; M Vargas; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  A second large plasmid encodes conjugative transfer and antimicrobial resistance in O119:H2 and some typical O111 enteropathogenic Escherichia coli strains.

Authors:  Adaobi I Nwaneshiudu; Tania Mucci; Derek J Pickard; Iruka N Okeke
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

3.  Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.

Authors:  Jessica C Seidman; Christian L Coles; Ellen K Silbergeld; Joshua Levens; Harran Mkocha; Lashaunda B Johnson; Beatriz Muñoz; Sheila K West
Journal:  Int J Epidemiol       Date:  2014-03-21       Impact factor: 7.196

4.  High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru.

Authors:  Theresa J Ochoa; Joaquím Ruiz; Margarita Molina; Luis J Del Valle; Martha Vargas; Ana I Gil; Lucie Ecker; Francesca Barletta; Eric Hall; Thomas G Cleary; Claudio F Lanata
Journal:  Am J Trop Med Hyg       Date:  2009-08       Impact factor: 2.345

Review 5.  Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare.

Authors:  Katarina Ilić; Emil Jakovljević; Vesna Skodrić-Trifunović
Journal:  Eur J Pediatr       Date:  2011-10-07       Impact factor: 3.183

6.  Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam.

Authors:  Trung Vu Nguyen; Phung Van Le; Chinh Huy Le; Andrej Weintraub
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

7.  Error-prone DNA repair system in enteroaggregative Escherichia coli identified by subtractive hybridization.

Authors:  Lucy M Joo; Louissa R Macfarlane-Smith; Iruka N Okeke
Journal:  J Bacteriol       Date:  2007-03-09       Impact factor: 3.490

8.  Multi-locus sequence typing of enteroaggregative Escherichia coli isolates from Nigerian children uncovers multiple lineages.

Authors:  Iruka N Okeke; Faith Wallace-Gadsden; Hannah R Simons; Nicholas Matthews; Amy S Labar; Jennifer Hwang; John Wain
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

9.  Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil.

Authors:  Isabel C A Scaletsky; Tamara B Souza; Katia R S Aranda; Iruka N Okeke
Journal:  BMC Microbiol       Date:  2010-01-27       Impact factor: 3.605

10.  Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042.

Authors:  Roy R Chaudhuri; Mohammed Sebaihia; Jon L Hobman; Mark A Webber; Denisse L Leyton; Martin D Goldberg; Adam F Cunningham; Anthony Scott-Tucker; Paul R Ferguson; Christopher M Thomas; Gad Frankel; Christoph M Tang; Edward G Dudley; Ian S Roberts; David A Rasko; Mark J Pallen; Julian Parkhill; James P Nataro; Nicholas R Thomson; Ian R Henderson
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.